Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator

International Journal of Cancer

Volumn 73, Issue 5, 1997, Pages 740-748

  Tiberio, Antonella ^a   Farina, Antonietta R ^a,b   Tacconelli, Antonella ^a   Cappabianca, Lucia ^a   Gulino, Alberto ^a   Mackay, Andrew R ^a,b,c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOMATERIAL; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COLLAGEN; LAMININ; MATRIGEL; METALLOPROTEINASE; NERVE GROWTH FACTOR RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN TYROSINE KINASE; PROTEOGLYCAN; RETINOIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL CULTURE; CELL DIVISION; DRUG COMBINATION; DRUG EFFECT; HUMAN; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PHENOTYPE;

ANTINEOPLASTIC AGENTS; BASEMENT MEMBRANE; BIOCOMPATIBLE MATERIALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIVISION; COLLAGEN; DRUG COMBINATIONS; HUMANS; LAMININ; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEUROBLASTOMA; PHENOTYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEOGLYCANS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKB; RECEPTORS, NERVE GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE PLASMINOGEN ACTIVATOR; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031588367     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971127)73:5<740::AID-IJC22>3.0.CO;2-8     Document Type: Article

References (36)

1. ALBINI, A., IWAMOTO, Y., KLEINMAS, H.K., MARTIN, G.R., AARONSON, S.A., KOZLOWSKI, J.M. and MCEWAN, T.N., A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
2. BULENS, F., IBANEZ-TALLON, I., VAN ACKER, P., DE VRIESE, A., NELLES, L., BELAYEW, A. and COLLEN, D., Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases. J. biol. Chem., 270, 7167-7175 (1995).
3. CESARMAN, G.M., GUEVARA, C.A. and HAJJAR, A., An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). J. biol. Chem., 269, 21198-21203 (1994).
4. CICCARONE, V., SPENGLER, B.A., MEYERS, M.B., BIEDLER, J.L. and ROSS, R.A., Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49, 219-255 (1989).
5. COTTAM, D.W. and REES, R.C., Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int. J. Oncol., 2, 861-872 (1993).
6. DE VEAS, R.G., SCHWEIGERER, L. and MEDINA, M.A., Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in pediatric tumor cells. Effects of tumour cell proliferation modulators on gelatinase activity. J. Cancer Res. clin. Oncol., 121, 275-278 (1995).
7. FARINA, A.R., TIBERIO, A., TACCONELLI, A., CAPPABIANCA, L., GULINO, A. and MACKAY, A.R., Identification of plasminogen in matrigel and its activation by plasminogen activators endogenous to this tumor basement membrane extract. Biotechniques, 21, 904-909 (1996).
8. FESTUCCIA, C., BOLOGNA, M., VICENTINI, C., TACCONELLI, A., MIANO, R., VIOLINI, S. and MACKAY, A.R., Increased matrix metalloproteinase-9 secretion in short term tissue cultures of prostatic tumor cells. Int. J. Cancer (Pred. Oncol.), 69, 1-8 (1996).
9. GIGUÉRE, V., Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalling. Endocrine Rev., 15, 61-79 (1994).
10. HANADA, M., KRAJEWSKI, S., TANAKA, S., CAZALS-HATEM, D., SPENGLER, B.A., ROSS, R.A., BIEDLER, J.L. and REED, J.C., Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res., 53, 4978-4986 (1993).
11. HENDRIX, M.J.C. and 12 OTHERS, Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res., 50, 4121-4130 (1990).
12. LAFYATIS, R., KIM, S.-J., ANGEL, P., ROBERTS, A.B., SPORN, M.B., KARIN, M. and WILDER, R.L., Interleukin-1 and all-trans retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol. Endocrinol., 4, 973-980 (1990).
13. LASORELLA, A., LAVARONE, A. and ISRAEL, M., Differentiation of neuroblastoma enhances Bcl2 expression and induces alterations of apoptosis and drug resistance. Cancer Res., 55, 4711-4716 (1995).
14. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. (Suppl.)., 51, 5054-5059 (1991).
15. MACKAY, A.R., BALLIN, M., PELLINA, M.D., FARINA, A.R., NASON, A.M., HARTZLER, J.L. and THORGEIRSSON, U.P., Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12, 168-184 (1992).
16. MACKAY, A.R., CORBITT, R.H., HARTZLER, J.L. and THORGEIRSSON, U.P., Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res., 50, 5997-6001 (1990a).
17. MACKAY, A.R., HARTZLER, J.L., PELINA, M.D. and THORGEIRSSON, U.P., Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. biol. Chem., 265, 21929-21934 (1990b).
18. MATSUMOTO, K., WADA, R.K., YAMASHIRO, J.M., KAPLAN, D.R. and THIELE, C.J., Expression of bran-derived neurotrophic factor and p145TrkB affects survival, differentiation and invasiveness of human neuroblastoma cells. Cancer Res., 55, 1798-1806 (1995).
19. MERENMIES, J., PIHLASKARI, R., LAITINEN, J., WARTIOVAARA, J. and RAUVALA, H., 30-kDa heparin-binding protein of rat brain (amphoterin) involved in neurite outgrowth. J. biol. Chem., 266, 16722-16729 (1991).
20. NAKAJIMA, M., LOTAN, D., BAIG, M.M., CARRALERO, R.M., WOOD, W.R., HENDRIX, M.J.C. and LOTAN, R., Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res., 49, 1698-1706 (1989).
21. NEUMAN, T., STEPHENS, R.W., SALONEN, E.M., TIMMUSK, T. and VAHERI, A., Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue type plasminogen activator. J. Neurosci. Res., 23, 274-281 (1989).
22. NICOLSON, R.C., MADER, S., NAGPAL, S., LEID, M., ROCHETTE-EGLY, C. and CHAMBON, P., Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP-1 binding site. EMBO J., 9, 4443-4454 (1990).
23. OTTER, M., BERGSHOEFF, L. and RIJKEN, D.C., Binding of tissue-type plasminogen activator by the mannose receptor. J. biol. Chem., 266, 13931-13935 (1991).
24. PARKINNEN, J. and RAUVALA, H., Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. J. biol. Chem., 266, 16730-16735 (1991).
25. PITTMAN, R.N. and DIBENEDETTO, A.J., PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate taster than control cells in complex extracellular matrix. J. Neurochem., 64, 566-575 (1995).
26. RAYMOND, N.G. and KELLEN, J.A., The role of plasminogen activators in metastasis. Med Hypotheses, 10, 291-293 (1983).
27. RETTIG, W.J., SPENGLER, B.A., GARIN-CHESA, P., OLD, L.J. and BIEDLER, J.L., Co-ordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res., 47, 1383-1389 (1987).
28. ROSS, R.A., SPENGLER, B.A. and BIEDLER, J.L., Co-ordinate morphological and biochemical interconversion of human neuroblastoma cells. J. nat. Canc. Inst., 71, 741-749 (1983).
29. SEEGER, R.C., SEIGEL, S.E. and SIDELL, N., Neuroblastoma: clinical perspectives, monoclonal antibodies and retinoic acid. Ann. Intern. Med., 97, 873-884 (1982).
30. SIDELL, N., ALTMAN, A., HAUSSLER, M.R. and SEEGER, R.C., Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp. Cell Res., 148, 21-30 (1983).
31. STAHL, A. and MUELLER, B.M., Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res., 54, 3066-3071 (1994).
32. STEFANSSON, S. and LAWRENCE, D.A., The serpin PAI-1 inhibits cell migration by blocking integrin alphaV beta3 binding to vitronectin. Nature (Lond.), 383, 441-143 (1996).
33. STETLER-STEVENSON, W.G., KRUTZSCH, H.C. and LIOTTA, L.A., Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. biol. Chem., 264, 17374-17378 (1989).
34. SUGIURA, Y., LAUG, W.E., SUN, B., SEEGER, R.C. and DECLERCK, Y.A., Expression of plasminogen activators and their inhibitors in human neuroblastomas. Proc. Amer. Ass. Cancer Res., 38, 410 (1997).
35. TISCHLER, A.L., DICHTER, M.A., BIALIS, B. and GREEN, L.A., Neuroendocrine neoplasms and their cells of origin. N. Eng. J. Med., 296, 919-924 (1977).
36. UNEMESONO, K., GIGUÈRE, V., CHRISTOFER, C.K., ROSENFELD, M.G. and EVENS, M., Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature (Lond.)., 336, 262-264 (1988).